News - OxyDial Inc

Feb 27 2024

NCDHHS working with the federal government on increasing access to sickle cell disease treatment

Sickle cell disease affects a significant number of individuals in North Carolina, particularly within the Black community, where about 95 percent of cases are found. This genetic blood disorder not …

OxyDial

Feb 20 2024

Fewer infections in youth with sickle cell anemia on hydroxyurea

A recent study conducted in Uganda revealed that treatment with hydroxyurea significantly reduced the incidence of severe or invasive infections among children with sickle cell anemia by 60%. Sickle cell …

OxyDial

Feb 13 2024

Stem cell therapy BEAM-101 dosed to 1st patient in BEACON trial

The first patient has been administered with BEAM-101 in the BEACON trial, a Phase 1/2 clinical study conducted by Beam Therapeutics for sickle cell disease (SCD). Following the transplantation, stem …

OxyDial

Feb 9 2024

Sickle Cell Treatment Endari by Emmaus Now Available in the United States

Emmaus Life Sciences has launched Endari, a medication aimed at alleviating acute complications in individuals battling sickle cell disease, now accessible via prescription across the United States. Sickle cell disease, …

OxyDial

Feb 6 2024

Approved Legislation for Sickle Cell Disease Pilot Program

In a significant move to address health disparities and enhance care for individuals with sickle cell disease (SCD) in New Jersey, Governor Phil Murphy signed legislation appropriating $10.2 million for …

OxyDial

Jan 30 2024

How AI revolutionized drug and vaccine development

CES 2024, themed “AI in Everything,” has prompted various industries to explore interdisciplinary integration, with the AI medical sector serving as a prominent example. Moderna, a pharmaceutical tech giant, has …

OxyDial

Jan 23 2024

Blue Cross first to open sickle cell gene therapy floodgates

Bluebird bio’s CEO, Andrew Obenshain, defends the 40% premium on the list price of the gene therapy Lyfgenia compared to competitors Vertex and CRISPR Therapeutics. Obenshain highlights the outcomes-based contracts, …

OxyDial

Jan 16 2024

AI model predicts aging and disease risk using facial and retinal images

In a groundbreaking study published in the Proceedings of the National Academy of Sciences, a team of Chinese scientists introduced an innovative approach to aging and disease prediction. Utilizing a …

OxyDial

Jan 9 2024

What’s New: Advancements in Sickle Cell Disease Therapies

Delve into the latest advancements in Sickle Cell Disease therapies with DelveInsight’s comprehensive report. Covering FDA, EMA, and PDMA approvals, clinical trials, mechanisms, and key companies like Bellicum Pharmaceuticals, Novartis, …